Cargando…

Icariin Prevents Diabetes-Induced Bone Loss in Rats by Reducing Blood Glucose and Suppressing Bone Turnover

Diabetic Osteoporosis (DOP) is a common metabolic bone disease, characterized by decreased bone mineral density (BMD) and destruction of bone microstructure. It has been reported that icariin is beneficial for estrogen deficiency-induced osteoporosis, and alcohol-induced osteoporosis; whether icarii...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Shanshan, He, Jia, Zheng, Hongxing, Chen, Chen, Lan, Shiqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571757/ https://www.ncbi.nlm.nih.gov/pubmed/31096652 http://dx.doi.org/10.3390/molecules24101871

Ejemplares similares

The Beneficial Effect of Proanthocyanidins and Icariin on Biochemical Markers of Bone Turnover in Rats
por: Oršolić, Nada, et al.
Publicado: (2018)

Icariin Prevents Cartilage and Bone Degradation in Experimental Models of Arthritis
por: Chao Wei, Chen, et al.
Publicado: (2016)

Salidroside Improves Bone Histomorphology and Prevents Bone Loss in Ovariectomized Diabetic Rats by Upregulating the OPG/RANKL Ratio
por: Zheng, Hongxing, et al.
Publicado: (2018)

Effects of Icariin on Modulating Gut Microbiota and Regulating Metabolite Alterations to Prevent Bone Loss in Ovariectomized Rat Model
por: Wang, Shanshan, et al.
Publicado: (2022)

Icariin prevents oestrogen deficiency–induced alveolar bone loss through promoting osteogenesis via STAT3
por: Xu, Hongyuan, et al.
Publicado: (2020)

Icariin treatment reduces blood glucose levels in type 2 diabetic rats and protects pancreatic function
por: Li, Xin, et al.
Publicado: (2020)

Icariin attenuates thioacetamide-induced bone loss via the RANKL-p38/ERK-NFAT signaling pathway
por: Cheng, Linyan, et al.
Publicado: (2022)

Icariin Enhances Bone Repair in Rabbits with Bone Infection during Post-infection Treatment and Prevents Inhibition of Osteoblasts by Vancomycin
por: Zhang, Yang, et al.
Publicado: (2017)

Paradoxical Response to Mechanical Unloading in Bone Loss, Microarchitecture, and Bone Turnover Markers
por: Sun, Xiaodi, et al.
Publicado: (2015)

Mechanism of Action of Icariin in Bone Marrow Mesenchymal Stem Cells
por: Yang, Aofei, et al.
Publicado: (2019)

Amlexanox Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss
por: Zhang, Yong, et al.
Publicado: (2015)

Evaluating Bone Loss with Bone Turnover Markers Following Acute Spinal Cord Injury
por: Thakkar, Prince, et al.
Publicado: (2020)

Effects of blood flow restriction training on bone turnover markers, microstructure, and biomechanics in rats
por: Song, Yawei, et al.
Publicado: (2023)

Icariin Reduces Dopaminergic Neuronal Loss and Microglia-Mediated Inflammation in Vivo and in Vitro
por: Wang, Guo-Qing, et al.
Publicado: (2018)

Bone microarchitecture and bone turnover in hepatic cirrhosis
por: Wakolbinger, R., et al.
Publicado: (2019)

The Change of Bone Turnover Markers and Bone Remodelling Balance in Acromegaly
por: Chen, Huan, et al.
Publicado: (2021)

The effects of icariine concentration on osteoclasts bone resorption induced by titanium particles in vitro
por: Zhang, Yiyuan, et al.
Publicado: (2015)

Nanotherapy for bone repair: milk-derived small extracellular vesicles delivery of icariin
por: Yu, Xinxin, et al.
Publicado: (2023)

Effect of Intravenous Glucose Tolerance Test on Bone Turnover Markers in Adults with Normal Glucose Tolerance
por: Xiang, Shou-Kui, et al.
Publicado: (2016)

Circulating markers of bone turnover
por: Vervloet, Marc G., et al.
Publicado: (2017)

Daily parathyroid hormone administration enhances bone turnover and preserves bone structure after severe immobilization‐induced bone loss
por: Harlow, Lauren, et al.
Publicado: (2017)

Inhibition of PFKFB3 suppresses osteoclastogenesis and prevents ovariectomy‐induced bone loss
por: Wang, Jia, et al.
Publicado: (2019)

Icariin Treatment Rescues Diabetes Induced Bone Loss via Scavenging ROS and Activating Primary Cilia/Gli2/Osteocalcin Signaling Pathway
por: Liu, Jie, et al.
Publicado: (2022)

Osteogenic Enhancement Between Icariin and Bone Morphogenetic Protein 2: A Potential Osteogenic Compound for Bone Tissue Engineering
por: Zhang, Xin, et al.
Publicado: (2019)

The Dose-Effect of Icariin on the Proliferation and Osteogenic Differentiation of Human Bone Mesenchymal Stem Cells
por: Fan, Jun-Jun, et al.
Publicado: (2011)

Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine
por: Haskelberg, Hila, et al.
Publicado: (2012)

In patients with anorexia nervosa, myokine levels are altered but are not associated with bone mineral density loss and bone turnover alteration
por: Maïmoun, Laurent, et al.
Publicado: (2022)

Effects of weight loss on bone turnover, inflammatory cytokines, and adipokines in Chinese overweight and obese adults
por: Yu, D., et al.
Publicado: (2022)

Bone turnover is adequately suppressed in osteoporotic patients treated with bisphosphonates in daily practice
por: Eekman, Danielle A, et al.
Publicado: (2011)

Changes in Bone Turnover Markers and Bone Mass with Reducing Levels of Jumping Exercise Regimens in Female Rats
por: Ooi, Foong Kiew, et al.
Publicado: (2012)

Potential role of microRNA-503 in Icariin-mediated prevention of high glucose-induced endoplasmic reticulum stress
por: Su, Bao-Lin, et al.
Publicado: (2023)

Specnuezhenide suppresses diabetes-induced bone loss by inhibiting RANKL-induced osteoclastogenesis: Specnuezhenide suppresses diabetes-induced bone loss
por: Ye, Xiaoshuang, et al.
Publicado: (2022)

Effect of Dietary Geranylgeraniol and Green Tea Polyphenols on Glucose Homeostasis, Bone Turnover Biomarkers, and Bone Microstructure in Obese Mice
por: Shen, Chwan-Li, et al.
Publicado: (2023)

Familial longevity is associated with lower baseline bone turnover but not differences in bone turnover in response to rhTSH
por: Zutinic, Ana, et al.
Publicado: (2021)

Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL, and OYL
por: Niu, Chi-Chien, et al.
Publicado: (2017)

Serum Sclerostin and Its Association with Bone Turnover Marker in Metabolic Bone Diseases
por: Chen, Lihui, et al.
Publicado: (2022)

Icariin Promotes Tendon-Bone Healing during Repair of Rotator Cuff Tears: A Biomechanical and Histological Study
por: Ye, Chenyi, et al.
Publicado: (2016)

Bone loss: Therapeutic approaches for preventing bone loss in inflammatory arthritis
por: Rehman, Qaiser, et al.
Publicado: (2001)

Biochemical markers of bone turnover and their association with bone marrow lesions
por: Hunter, David J, et al.
Publicado: (2008)

Diabetes, Biochemical Markers of Bone Turnover, Diabetes Control, and Bone
por: Starup-Linde, Jakob
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9emqhg3e5fovlku5ato89r2pml